title: Fluoxetine in posttraumatic eating disorder in two-year-old twins.
abstract: Feeding disorders of infancy or early childhood are relatively uncommon in the pediatric population. In posttraumatic eating disorder, the infant demonstrates food refusal after a traumatic event or repeated traumatic events to the oropharynx or esophagus. We present case reports of 24-month-old twin girls, A and B, who presented to our clinic with food refusal and fear of feeding. Several invasive gastrointestinal procedures were performed when they were 3 months old, and they started to refuse all solid food and some liquids soon after hospitalization. Fluoxetine 0.3 mg/kg per day (5 mg/day) was started to target their anxiety and fear about feeding. In the second month of weekly follow up, the children began to be fed without a nasogastric catheter. A significant decrease in anxiety and fear was observed during feeding. Although the use of serotonin-selective reuptake inhibitors (SSRIs) in preschool children is controversial due to the lack of empirical data in this age group, we observed clinical improvements in anxiety in these two cases. Furthermore, fluoxetine was well tolerated and no side effects were observed.
authors.affiliation: Department of Child and Adolescent Psychiatry, Cukurova University, Adana, Turkey 01330.
authors.forename: Gonca
authors.initials: G
authors.lastname: Celik
authors.forename: Rasim Somer
authors.initials: RS
authors.lastname: Diler
authors.forename: Aysegul Yolga
authors.initials: AY
authors.lastname: Tahiroglu
authors.forename: Ayşe
authors.initials: A
authors.lastname: Avci
mesh_terms: D002675:Child, Preschool; D013505:Digestive System Surgical Procedures / Q000523:psychology*; D019959:Feeding and Eating Disorders of Childhood / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
chemical_list: D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors